Investing.com - Novan reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novan announced earnings per share of $-0.25 on revenue of $5.11M. Analysts polled by Investing.com EPS of $-0.39 on revenue of $6.28M.
Novan 's are up 3.5% and is trading at $1.02 , still down 84.89% from its 52 week high of $6.75 set on Monday, November 15, 2021.
Novan follows other major Healthcare sector earnings this month
Novan's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar